Entries by Thomas Gabrielczyk

AMR: Big Pharma sets up US$1bn Fund

After leaving the field of antimicrobials 20 years ago because other areas offered better returns, 23 pharma companies and the Novo Foundation have launched a US$1bn fund to fight antimicrobial resistance (AMR).